Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) stock enjoyed a major increase of 25.5% on 3/19/24. The shares closed at $8.21. Moreover, exceptionally high trading volume at 862% of normal accompanied the advance. The stock has risen 18.6% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, ATNM is expected to continue to be Value Creation neutral.
Actinium Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. Actinium Pharmaceuticals has a slightly negative Power Rating of 35 and a very low Appreciation Score of 4, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment